Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · IEX Real-Time Price · USD
3.860
-0.050 (-1.28%)
At close: Apr 24, 2024, 4:00 PM
3.950
+0.090 (2.33%)
Pre-market: Apr 25, 2024, 8:03 AM EDT
Relmada Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for RLMD stock has a target of 26, which predicts an increase of 573.58% from the current stock price of 3.86.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 15, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for RLMD is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '23 | Feb '23 | Mar '23 | Apr '23 | May '23 | Jun '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +573.58% | Jun 15, 2023 |
| SVB Leerink | SVB Leerink | Buy Maintains $42 → $10 | Buy | Maintains | $42 → $10 | +159.07% | Jan 23, 2023 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $8 | Strong Buy → Hold | Downgrades | $8 | +107.25% | Oct 14, 2022 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 14, 2022 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Oct 13, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.12
from -3.28
EPS Next Year
-2.41
from -3.12
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 66.5M | 201.4M | 409.9M |
| Avg | n/a | n/a | 47.1M | 111.4M | 398.2M |
| Low | n/a | n/a | 28.4M | 26.1M | 382.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 327.9% | 268.0% |
| Avg | - | - | - | 136.6% | 257.5% |
| Low | - | - | - | -44.6% | 243.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.74 | -1.68 | -1.52 | -0.44 | 1.33 |
| Avg | -3.12 | -2.41 | -2.37 | -0.43 | 1.30 |
| Low | -3.72 | -4.04 | -3.31 | -0.41 | 1.24 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.